New Delhi, April 01, 2017: Narayana Hrudayalaya Surgical Hospital Private Limited, a wholly owned subsidiary of Narayana Hrudayalaya Limited, has entered into definitive agreements to partner with Dharamshila Cancer Foundation & Research Centre for the provision of healthcare services at ‘Dharamshila Hospital & Research Centre’ in Delhi. The facility, presently an oncology focused unit, would be upgraded to a state-of the-art superspeciality tertiary care unit.
Located in East Delhi, the hospital has been operational since 1994 and has achieved operating revenues of INR 595 mn for 9 months period ended December 2016. With a robust platform to make significant inroads in an attractive healthcare market like NCR, NH shall be committed to deliver high quality affordable healthcare services encompassing its core values of Innovation & Efficiency, Compassionate care, Accountability, Respect for all and Excellence as a culture.
Following NH’s asset-right engagement framework, this facility considerably reduces NH’s time-to- market with limited capital outlay. It bolsters NH’s newly established Northern cluster which includes Shri Mata Vaishno Devi Narayana Super Speciality Hospital in Kakriyal, Jammu which has received an overwhelming response within 1st year of operations.
Management Comment
Commenting on the announcement, Dr. Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said “ This marks our maiden foray in NCR and highlights our emphasis on asset-right model of growth. This is in line with our objective of creating a strong cluster around NCR like our existing ones in Karnataka and Eastern region. This opportunity allows us to capitalize on a significant head-start we get in terms of a hospital with over 20 years track record of profitable operations in a geography of our interest. We shall continue to scout for such meaningful opportunities in Northern India which could help cement our presence across the region.”
Corporate Comm India(CCI Newswire)
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…